Page last updated: 2024-10-25

cilostazol and Liver Dysfunction

cilostazol has been researched along with Liver Dysfunction in 2 studies

Research Excerpts

ExcerptRelevanceReference
"The pharmacokinetic profiles of cilostazol and its metabolites following a single oral dose of cilostazol 100 mg were compared between individuals with impaired and normal liver function."2.69Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazol. ( Bramer, SL; Forbes, WP, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nomura, K1
Miyashita, T1
Yamamoto, Y1
Munesue, S1
Harashima, A1
Takayama, H1
Fushida, S1
Ohta, T1
Bramer, SL1
Forbes, WP1

Trials

1 trial available for cilostazol and Liver Dysfunction

ArticleYear
Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazol.
    Clinical pharmacokinetics, 1999, Volume: 37 Suppl 2

    Topics: Administration, Oral; Adult; Area Under Curve; Cilostazol; Half-Life; Humans; Liver Diseases; Male;

1999

Other Studies

1 other study available for cilostazol and Liver Dysfunction

ArticleYear
Citrullinated Histone H3: Early Biomarker of Neutrophil Extracellular Traps in Septic Liver Damage.
    The Journal of surgical research, 2019, Volume: 234

    Topics: Animals; Biomarkers; Cilostazol; Citrullination; Extracellular Traps; Histones; Lipopolysaccharides;

2019